The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4542794 5701958 F 4542794-0 20041201 20041216 20041231 EXP PHNU2004DE04220 NOVARTIS PHARMACEUTICALS CORP. 70 YR M Y 20041231 MD

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4542794 1005547066 PS GLEEVEC 1 ORAL 400MG/DAY

Indications of drugs used

Event ID DRUG SEQ INDI PT
4542794 1005547066 CHRONIC MYELOID LEUKAEMIA

Outcome of event

Event ID OUTC COD
4542794 OT

Reactions reported

Event ID PT
4542794 BLADDER CATHETERISATION
4542794 DYSURIA
4542794 HYPERTONIC BLADDER
4542794 URINARY RETENTION

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4542794 1005547066 20040901